The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Investigational NEDD8-activating enzyme inhibitor pevonedistat (Pev) plus chemotherapy in patients (Pts) with solid tumors (Phase 1b study): Antitumor activity of pev plus carboplatin (Carbo)/Paclitaxel (Pac).
 
Todd Michael Bauer
No Relationships to Disclose
 
R Donald Harvey
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Takeda
Research Funding - Abbott Biotherapeutics (Inst); Acetylon Pharmaceuticals (Inst); Agensys (Inst); Amgen (Inst); ArQule (Inst); AstraZeneca (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Cleave Biosciences (Inst); Eisai (Inst); Genzyme (Inst); ImClone Systems (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Onyx (Inst); Pfizer (Inst); Sanofi (Inst); Synta (Inst)
 
Carrie B. Lee
Travel, Accommodations, Expenses - Novartis
 
Charu Aggarwal
Consulting or Advisory Role - Celgene (I); Genentech; Genentech (I)
Speakers' Bureau - Genentech (I); Novartis (I); Pfizer (I)
Research Funding - Genentech/Roche; Millennium; Nektar
 
Roger B. Cohen
Consulting or Advisory Role - Cerulean Pharma; GlaxoSmithKline; Heat Biologics; Kolltan Pharmaceuticals; Takeda
Research Funding - Heat Biologics (Inst); Macrogenics (Inst); Merck (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Cerulean Pharma; Heat Biologics; Kolltan Pharmaceuticals; Takeda
 
Farhad Sedarati
Employment - Millennium
Stock and Other Ownership Interests - Takeda
Travel, Accommodations, Expenses - Millennium
 
Zhaoyang Teng
Employment - Millennium
Stock and Other Ownership Interests - Gilead Sciences
Research Funding - Millennium
 
Hélène M. Faessel
Employment - Millennium
Stock and Other Ownership Interests - Takeda
 
Ajeeta Dash
Employment - Millennium
Stock and Other Ownership Interests - Takeda
Patents, Royalties, Other Intellectual Property - Sanofi
 
Bruce J. Dezube
Employment - Millennium
Stock and Other Ownership Interests - Takeda
 
Sergio Santillana
Employment - Millennium
Stock and Other Ownership Interests - Takeda
Patents, Royalties, Other Intellectual Property - Takeda
Other Relationship - GlaxoSmithKline
 
Afshin Dowlati
Consulting or Advisory Role - Boehringer Ingelheim; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Lilly/ImClone (Inst); MedImmune (Inst); OncoMed (Inst)
 
Albert C. Lockhart
Research Funding - Amgen (Inst); Bayer (Inst); CTI (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Lilly (Inst); Millennium (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Teva (Inst); Vertex (Inst); Zenyaku Kogyo (Inst)